Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Hematology
•
Pulmonology
•
Critical Care
•
Hospital Medicine
•
General Hospital Medicine
Do you commonly observe acute erythrocytosis in patients with ILD flares being treated with supplemental oxygen and high-dose corticosteroids?
If so, do you recommend any specific workup, monitoring, or intervention?
Related Questions
How do you decide whether to use pharmacologic VTE prophylaxis in hospitalized patients with decompensated cirrhosis?
What do you think about using conventional thoracic imaging methods (e.g., X-ray, CT, etc.) to determine if a pleural effusion is of adequate size to consider thoracentesis?
Do you ever consider sodium supplementation to augment diuresis in patients hospitalized with decompensated heart failure, as discussed in a recent systematic review and meta-analysis?
How do you weigh the benefit of urinary catheter placement for strict I/O measurement with the risk of avoidable CAUTI?
How do you approach caring for patients admitted with decompensated CHF, but who also exhibit hypotension and do not have overt signs of hypervolemia on exam?
Under what circumstances do you recommend POCUS guidance for lumbar puncture?
How do you recommend incorporating B-lines on lung POCUS as part of evaluating a patient's volume status?
How do you decide which IV opioid to use for symptom relief at the end of life?
When can we consider deferring an insulin drip in patients with hypertriglyceridemia-induced pancreatitis?
What are your thoughts on trending beta-hydroxybutyrate once a diagnosis of DKA is already established?